Ivy Brain Tumor Center and SonALAsense to test drug-device combination for glioblastoma
First-in-human clinical trial will determine effectiveness of promising, non-invasive therapy for brain cancerCredit: Ivy Brain Tumor Center The Ivy Brain ...
First-in-human clinical trial will determine effectiveness of promising, non-invasive therapy for brain cancerCredit: Ivy Brain Tumor Center The Ivy Brain ...
Groundbreaking discovery by FAU Harbor Branch, collaborators impacts marine biotechnology, early animal evolution and climate changeCredit: Shirley A. Pomponi, Ph.D. ...
CHOP cardiologists report milestone results for Fontan survivors in multicenter, phase 3 FUEL TrialCredit: Children's Hospital of Philadelphia The largest-ever ...
Would become first approved drug for genetic disorder affecting millionsCredit: Children's Tumor Foundation AstraZeneca and MSD (Merck) announced today that ...
Credit: the Babraham Institute The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved ...
Protein linked to tumor survival and spreadCredit: University of Houston In the world of cancer biology, not all biomarkers are ...
Credit: Hidefumi Makabe & Hiroshi Fujii, Institute for Biomedical Sciences, Shinshu University, Japan Grape stems are discarded en masse during ...
Scientists take closer look at use of 'drug of concern' kratomCredit: Purdue University/Richard van Rijn WEST LAFAYETTE, Ind. - Lawmakers ...
Sex-specific processes in schizophrenia and bipolar disorderCredit: Sebastian Lobentanzer FRANKFURT. Recent studies have found a high genetic similarity of the ...
Credit: Purdue University/R. Claudio Aguilar WEST LAFAYETTE, Ind. - Anthrax may soon help more people win the fight against bladder ...
Credit: LSU Health New Orleans New Orleans, LA - Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director ...
Credit: TTUHSC Neuroblastoma is the most common cancer outside of the brain in infants and young children and often fails ...
New technique to help explore genetic diseases, benefit drug developmentCredit: Dan Addison | UVA Communications Scientists at the University of ...
/Frankfurt/ CPhI-2019 became the first large-scale international platform to present the BIOCAD's latest original drugs based on monoclonal antibodies -- ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.